×
About 288 results

ALLMedicine™ Esthesioneuroblastoma Center

Research & Reviews  108 results

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).
https://clinicaltrials.gov/ct2/show/NCT05012098

May 13th, 2022 - Background: Olfactory neuroblastoma (ONB, also known as esthesioneuroblastoma), is a rare malignant neoplasm of the nasal cavity. At diagnosis, ONB is often locally advanced. It tends to invade locally and has high rates of regional spread to the ...

Minimally invasive pericranial flap harvest through a supraorbital eyebrow craniotomy: ...
https://doi.org/10.1016/j.clineuro.2022.107266
Clinical Neurology and Neurosurgery; Olson MG, Avery MB et. al.

May 10th, 2022 - The supraorbital eyebrow craniotomy is a minimally invasive approach that provides access to pathologies of the anterior and middle cranial fossae. Vascularized flaps are preferred when considering reconstructive options, however, small incisions ...

Impact of esthesioneuroblastoma treatment delays on overall patient survival.
https://doi.org/10.1002/lary.30136
The Laryngoscope; Tsutsumi K, Ahmed KH et. al.

Apr 24th, 2022 - To characterize clinical factors associated with esthesioneuroblastoma treatment delays and determine the impact of these delays on overall survival. Retrospective database analysis. The 2004-2016 National Cancer Database was queried for patients ...

Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 1...
https://doi.org/10.1002/alr.23007
International Forum of Allergy & Rhinology; McMillan RA, Van Gompel JJ et. al.

Apr 7th, 2022 - Esthesioneuroblastoma (ENB) is a rare malignant neoplasm arising from the olfactory epithelium of the cribriform plate. The goal of this study was to update our oncologic outcomes for this disease and explore prognostic factors associated with sur...

Influence of facility volume and type on esthesioneuroblastoma treatment and outcomes.
https://doi.org/10.1002/alr.22948
International Forum of Allergy & Rhinology; Goshtasbi K, Vasudev M et. al.

Dec 16th, 2021 - Influence of facility volume and type on esthesioneuroblastoma treatment and outcomes.|2021|Goshtasbi K,Vasudev M,Torabi SJ,Roman K,Abiri A,|

see more →

Clinicaltrials.gov  2 results

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).
https://clinicaltrials.gov/ct2/show/NCT05012098

May 13th, 2022 - Background: Olfactory neuroblastoma (ONB, also known as esthesioneuroblastoma), is a rare malignant neoplasm of the nasal cavity. At diagnosis, ONB is often locally advanced. It tends to invade locally and has high rates of regional spread to the ...

Esthesioneuroblastoma: Outcomes After Treatment
https://clinicaltrials.gov/ct2/show/NCT02580136

Feb 11th, 2021 - The purpose of this study is to collect and organize data into a repository to gather relevant information for future research from patients diagnosed with a rare malignant sinonasal cancer called esthesioneuroblastoma (ENB) and are scheduled to u...

see more →

News  1 results

Dana-Farber Announces Center for Salivary and Rare Head and Neck Cancers
https://www.onclive.com/view/dana-farber-announces-center-for-salivary-and-rare-head-and-neck-cancers

Oct 6th, 2021 - New center offers unique treatment and research opportunities largely unavailable elsewhere Dana-Farber Cancer Institute has launched the Center for Salivary and Rare Head and Neck Cancers to treat patients with rare and occasionally aggressive c...

see more →

Patient Education  4 results see all →